Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 689, pseudogene (RN7SL689P)

Target
RN7SL689P
Molecular classification
Pseudogene, Non-coding RNA
01

Overview

RNA, 7SL, cytoplasmic 689, pseudogene (RN7SL689P) is a human processed pseudogene related to the 7SL RNA, which is the RNA component of the signal recognition particle (SRP)[3][4][5][7][8]. Unlike functional 7SL RNA genes, which participate in the targeting of nascent proteins to the endoplasmic reticulum by binding ribosomes and facilitating translocation[1], RN7SL689P is a non-functional, non-coding genomic element resulting from the reverse flow of genetic information (retrotransposition) from 7SL RNA into DNA[3][7][8]. It is part of a large family of 7SL RNA pseudogenes, nearly all of which are truncated and non-expressed copies lacking canonical gene function[3][5][7][8]. While some pseudogenic non-coding RNAs have regulatory roles (e.g., miRNA sponging or ceRNA activity[2]), no evidence demonstrates RN7SL689P functions as a therapeutic target, nor interacts with drugs, nor serves as a biomarker. Its designation as a pseudogene means it lacks protein-coding and known biological activity, though it may retain epigenetic marks linked to transcriptional activity in rare cases[2][6]. RN7SL689P is not a canonical drug target, receptor, or enzyme, and is generally annotated for genomic characterization rather than functional or clinical use[3][5][7][8]. Its presence in human DNA reflects the evolutionary history and diversity of pseudogene biogenesis, most notably through RNA-driven retrotransposition[3][7][8].

Other names
RN7SL689P7SL RNA pseudogene7SL pseudogene

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 689, pseudogene (RN7SL689P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 689, pseudogene (RN7SL689P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call